- Home
- INFU vs AMRN Comparison
INFU vs AMRN Comparison
Compare INFU & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFU
- AMRN
- Stock Information
- Founded
- INFU 2005
- AMRN 1989
- Country
- INFU United States
- AMRN Ireland
- Employees
- INFU N/A
- AMRN N/A
- Industry
- INFU Medical/Dental Instruments
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- INFU Health Care
- AMRN Health Care
- Exchange
- INFU Nasdaq
- AMRN Nasdaq
- Market Cap
- INFU 104.4M
- AMRN 216.0M
- IPO Year
- INFU N/A
- AMRN 1993
- Fundamental
- Price
- INFU $5.61
- AMRN $16.08
- Analyst Decision
- INFU
- AMRN Strong Sell
- Analyst Count
- INFU 0
- AMRN 1
- Target Price
- INFU N/A
- AMRN $12.00
- AVG Volume (30 Days)
- INFU 280.5K
- AMRN 173.6K
- Earning Date
- INFU 08-07-2025
- AMRN 07-30-2025
- Dividend Yield
- INFU N/A
- AMRN N/A
- EPS Growth
- INFU 3654.89
- AMRN N/A
- EPS
- INFU 0.15
- AMRN N/A
- Revenue
- INFU $137,582,000.00
- AMRN $214,112,000.00
- Revenue This Year
- INFU $11.08
- AMRN N/A
- Revenue Next Year
- INFU $8.02
- AMRN N/A
- P/E Ratio
- INFU $38.84
- AMRN N/A
- Revenue Growth
- INFU 7.98
- AMRN N/A
- 52 Week Low
- INFU $4.61
- AMRN $7.08
- 52 Week High
- INFU $9.97
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- INFU 56.42
- AMRN 71.53
- Support Level
- INFU $6.09
- AMRN $16.12
- Resistance Level
- INFU $6.40
- AMRN $17.49
- Average True Range (ATR)
- INFU 0.26
- AMRN 0.96
- MACD
- INFU -0.02
- AMRN 0.05
- Stochastic Oscillator
- INFU 65.71
- AMRN 90.37
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.